Zenodo (CERN)
open access
CC BY 4.0
Nonclinical Safety Characterization of a Covalent KRAS G12C Inhibitor for FDA IND Submission: A Toxicology and Drug Interaction Analysis
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age#181597
- QTX3046 in Patients With KRAS G12D Mutations#837417
- Study to Determine the Effect of Ketoconazole on the Pharmacokinetics of GDC-0980#878525
- Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly#966585
- A Drug-Drug Interaction Study of Furosemide and PA21#836470
Record · ID 638179
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive